Trending

kidney

AstraZeneca shows cardiovascular safety for roxadustat

AstraZeneca shows cardiovascular safety for roxadustat

AstraZeneca has announced that pooled analyses of the phase III trials for its kidney disease drug roxadustat confirm

X

AstraZeneca shows cardiovascular safety for roxadustat

https://pharmaphorum.com/news/astrazeneca-shows-cardiovascular-safety-for-roxadustat/

Spain’s Sanifit chasing calcium disorder blockbuster

Spain’s Sanifit chasing calcium disorder blockbuster

Spanish biotech Sanifit is targeting calcification disorders, and says it could have a potential multi-billion dollar treatment in

X

Spain’s Sanifit chasing calcium disorder blockbuster

https://pharmaphorum.com/news/spains-sanifit-chasing-calcium-disorder-blockbuster/

NICE rejects Opdivo in advanced kidney cancer

NICE rejects Opdivo in advanced kidney cancer

NICE said survival benefits are unclear.

X

NICE rejects Opdivo in advanced kidney cancer

https://pharmaphorum.com/news/nice-rejects-bms-opdivo-advanced-kidney-cancer/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com